ALLMedicine™ Graves Disease Center
Research & Reviews 446 results
https://doi.org/10.1016/j.mayocp.2022.12.013
Mayo Clinic Proceedings; Naser JA, Pislaru SV et. al.
Mar 16th, 2023 - To describe the incidence, risk factors, and outcomes of incident atrial fibrillation (AF) in Graves disease (GD). Patients with GD between January 1, 2009, and December 31, 2019, were included retrospectively. We defined GD-related AF as AF diagn...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939848
The American Journal of Case Reports; Almazrouei O, Alalawi F et. al.
Feb 16th, 2023 - BACKGROUND Tocilizumab is a therapeutic biologic antagonist of the interleukin-6 (IL-6) receptor that has been approved to treat some autoimmune and chronic inflammatory diseases. This report is of a patient with a history of Graves disease and se...
https://emedicine.medscape.com/article/279462-print
Feb 7th, 2023 - Practice Essentials Hürthle cell carcinoma of the thyroid gland is an unusual and relatively rare type of differentiated thyroid cancer.[1] Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few ins...
https://emedicine.medscape.com/article/279462-overview
Feb 7th, 2023 - Practice Essentials Hürthle cell carcinoma of the thyroid gland is an unusual and relatively rare type of differentiated thyroid cancer. [1] Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few in...
http://emedicine.medscape.com/article/279462-overview
Feb 7th, 2023 - Practice Essentials Hürthle cell carcinoma of the thyroid gland is an unusual and relatively rare type of differentiated thyroid cancer. [1] Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few in...
Clinicaltrials.gov 21 results
https://clinicaltrials.gov/ct2/show/NCT05678374
Jan 10th, 2023 - Mental fatigue occurs in many diseases and the reasons are mostly unknown. The investigators hypothesize that remaining mental fatigue after restored hyperthyroidism in Graves' disease is an autoimmune complication. The aim of this study is to exp...
https://clinicaltrials.gov/ct2/show/NCT05643365
Dec 12th, 2022 - Hyperthyroidism is a clinical syndrome caused by increased thyroid hormone in the blood, it can lead to multiple complications, including cardiac, hepatic, and hematologic system complications. More than 80% of hyperthyroidism are caused by Graves...
https://clinicaltrials.gov/ct2/show/NCT05532072
Sep 8th, 2022 - Project basis: Thyroid-associated ophthalmopathy (GO), a vision-threatening autoimmune disease, is the most common extrathyroidal manifestation of Graves disease. At present, GO treatment is still dominated by hormone therapy. From 2010 to 2018, t...
https://clinicaltrials.gov/ct2/show/NCT05043233
Sep 14th, 2021 - Graves' disease is the main cause of clinically hyperthyroidism, accounting for about 75% to 80%, and it occurs in women of childbearing age. Clinical manifestations include: high eating, weight loss, sweating, palpitations, emotional excitement a...
https://clinicaltrials.gov/ct2/show/NCT02311361
Apr 20th, 2021 - Background: Tremelimumab is a monoclonal antibody against cytotoxic T-lymphocyte-associated protein 4 (CTLA4). Anti-CTLA4 therapy has been shown to enhance anti-tumor immunity by blocking tumor-induced immune suppression of cytotoxic T cells. Durv...
News 77 results
https://www.medscape.com/viewarticle/983455
Nov 3rd, 2022 - The study covered in this summary was published on Research Square as a preprint has not yet been peer reviewed. Key Takeaway Among women with hypoparathyroidism, bone mineral density (BMD) was increased, and there was no increase in fracture risk...
https://www.mdedge.com/dermatology/article/256823/hair-nails/nail-changes-associated-thyroid-disease
Angela Rosenberg, OMS-IV, Shari R. Lipner, MD, PhD
Aug 4th, 2022 - The major classifications of thyroid disease include hyperthyroidism, which is seen in Graves disease, and hypothyroidism due to iodine deficiency and Hashimoto thyroiditis, which have potentially devastating health consequences. The prevalence of.
https://www.medscape.com/viewarticle/973869
Jul 7th, 2022 - This transcript has been edited for clarity. Angela Leung, MD, MSc: Welcome to this video commentary about the long-term use of antithyroid drugs in the management of Graves disease. My name is Angela Leung. I'm an adult endocrinologist at the Uni...
https://www.medscape.com/viewarticle/972208
Apr 21st, 2022 - Matthew I. Balcerek, BExSci, MBBS COVID-19 has caused disease in close to 500 million people worldwide, according to the World Health Organization. While the airways are its primary target, SARS-CoV-2 may enter many organs via the protein angioten...
https://www.mdedge.com/dermatology/article/252083/dermatopathology/treatment-elephantiasic-pretibial-myxedema-rituximab
Shaan Patel, MD, MBA, David Choi, MD et. al.
Feb 23rd, 2022 - To the Editor: Pretibial myxedema (PTM) is bilateral, nonpitting, scaly thickening and induration of the skin that most commonly occurs on the anterior aspects of the legs and feet. Pretibial myxedema occurs in approximately 0.